Investment bank · United States

Wedbush Securities

Deals
19
M&A
10
Equity raisings
9
Latest
Sep 2026
Compare

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deal size
Custom range

19 of 19 deals

Deals Wedbush Securities advised on, most recent first
Advisers
Sep 2026 Aethlon Medical ––MergerFinancial adviser to North ImmunologyAnnounced–Biotech Gibson DunnMaxim GroupProcopio, Cory, Hargreaves & Savitch North Immunology and Aethlon Medical merger
Aug 2026 Slate Medicines –Fulcrum TherapeuticsMergerFinancial adviser to Slate Medicines (target)Announced–Biotech+1 Cooley (sell-side)Leerink Partners (buy-side)Goodwin (buy-side) Fulcrum Therapeutics and Slate Medicines merger
Aug 2026 Redx Pharma –Skye BioscienceAcquisitionFinancial adviser to Redx Pharma (target)Announced–Biotech+1 Stifel (buy-side)Morrison & Foerster (buy-side)Cooley (sell-side) Skye Bioscience acquisition of Redx Pharma
Aug 2026 Cy Biopharma –Ensysce BiosciencesAcquisitionFinancial adviser to Cy Biopharma (target)Completed–Biotech+1 Troutman Pepper Locke (buy-side)Orrick (sell-side)Tungsten Advisors (buy-side)H.C. Wainwright & Co. Ensysce Biosciences acquisition of Cy Biopharma
Jul 2026 Avere Therapeutics ––PlacementPlacement agent to the lead managersAnnounced320.0Biotech+1 Cooley (lead manager)Jefferies (lead manager)Sullivan & CromwellGibson Dunn (issuer) Avere Therapeutics placement
Jul 2026 Avere Therapeutics –NextCureMergerFinancial adviser to Avere Therapeutics (target)Announced–Biotech+1 Sullivan & CromwellSidley AustinGibson Dunn (sell-side)Tungsten Advisors (buy-side) NextCure and Avere Therapeutics merger
Jul 2026 SK hynix ––IPOUnderwriterAnnounced26,507.1Hardware & Semiconductors BofA Securities (lead manager)Citi (lead manager)Goldman Sachs (lead manager)J.P. Morgan (lead manager)Cantor Fitzgerald (lead manager)Mizuho Securities (lead manager)Needham & Company (lead manager)RBC Capital Markets (lead manager)Rosenblatt Securities (lead manager)Stifel (lead manager)William Blair (lead manager)Nomura (lead manager)WR Securities (lead manager)Cleary Gottlieb Steen & Hamilton (issuer)Paul Hastings (lead manager)Shin & Kim (issuer)Kim & Chang (lead manager) SK hynix IPO
Jun 2026 Remix Therapeutics –Passage BioMergerFinancial adviserPending–Biotech+2 Latham & Watkins (sell-side)Fenwick & West (buy-side)RBC Capital MarketsCanaccord Genuity Passage Bio and Remix Therapeutics merger
Jun 2026 Serapha Bio –Boundless BioMergerFinancial adviser to Serapha Bio (target)Pending–Biotech+1 Lucid Capital Markets (buy-side)Latham & Watkins (buy-side)Gibson Dunn (sell-side)Goodwin (sell-side) Boundless Bio and Serapha Bio merger
Jun 2026 Standard BioTools ––MergerFinancial adviser to Treeline Biosciences (target)Pending460.0Biotech+2 Centerview Partners (buy-side)Freshfields (buy-side)Richards, Layton & Finger (buy-side)UBS (buy-side)Fenwick & West (sell-side) Treeline Biosciences and Standard BioTools merger
May 2026 Mentari Therapeutics –InMed PharmaceuticalsAcquisitionFinancial adviser to Mentari Therapeutics (target)Announced–Biotech+1 Lucid Capital Markets (buy-side)Norton Rose Fulbright (buy-side)Gibson Dunn (sell-side) InMed Pharmaceuticals acquisition of Mentari Therapeutics
May 2026 Mentari Therapeutics ––PlacementPlacement agent to the lead managersAnnounced290.0Biotech+1 Cooley (lead manager)Gibson Dunn (issuer)Jefferies (lead manager)TD Securities (lead manager)Stifel (lead manager)Guggenheim Securities (lead manager) Mentari Therapeutics placement
May 2026 Cerebras Systems ––IPOUnderwriterListed5,550.0Hardware & Semiconductors+1 Morgan Stanley (lead manager)Citi (lead manager)Barclays (lead manager)UBS (lead manager)Mizuho Securities (lead manager)TD Securities (lead manager)Needham & Company (lead manager)Craig-Hallum (lead manager)Rosenblatt Securities (lead manager)Academy Securities (lead manager)MUFG (lead manager)Crédit Agricole CIB (issuer)Latham & Watkins (issuer)Davis Polk (lead manager) Cerebras Systems IPO
May 2026 Odyssey Therapeutics ––IPOUnderwriter and joint lead managerAnnounced279.0Biotech+1 J.P. Morgan (lead manager)TD Securities (lead manager)Cantor Fitzgerald (lead manager)Oppenheimer & Co. (lead manager)Covington & Burling (issuer)Cooley (lead manager) Odyssey Therapeutics IPO
May 2026 Odyssey Therapeutics ––PlacementPlacement agent to the lead managersPending25.0Biotech+1 J.P. Morgan (lead manager)TD Securities (lead manager)Cantor Fitzgerald (lead manager)Oppenheimer & Co. (lead manager)Cooley (lead manager) Odyssey Therapeutics placement
Apr 2026 Hemab Therapeutics Holdings ––IPOLead managerAnnounced301.5Biotech+1 Goldman Sachs (lead manager)Jefferies (lead manager)Evercore (lead manager)WilmerHale (issuer)Goodwin (lead manager) Hemab Therapeutics Holdings IPO
Mar 2026 Candid Therapeutics –RallybioAcquisitionFinancial adviser to Candid (target)Pending–Biotech+1 Cooley (sell-side)Evercore (buy-side)Citizens JMP (buy-side)Ropes & Gray (buy-side) Rallybio acquisition of Candid Therapeutics
Jan 2026 EquipmentShare.com ––IPOBookrunnerListed747.3Industrial Services+2 Davis Polk (issuer)Latham & Watkins (lead manager)Holland & Knight (issuer)Goldman Sachs (lead manager)Wells Fargo Securities (lead manager)UBS (lead manager)Citi (lead manager)Guggenheim Securities (lead manager)Citizens JMP (lead manager)Truist Securities (lead manager)Baird (lead manager)Oppenheimer & Co. (lead manager)KeyBanc Capital Markets (lead manager)Fifth Third Securities (lead manager)SMBC Nikko Securities (lead manager)M&T Securities (lead manager)Regions Securities (lead manager)BTIG (lead manager) EquipmentShare.com IPO
Jan 2026 BitGo Holdings ––IPOUnderwriterAnnounced212.8Crypto & Web3 Goldman Sachs (lead manager)Citi (lead manager)Deutsche Bank (lead manager)Mizuho Securities (lead manager)Wells Fargo Securities (lead manager)Keefe, Bruyette & Woods (lead manager)Canaccord Genuity (lead manager)Cantor Fitzgerald (lead manager)Clear Street (lead manager)Compass Point Research & Trading (lead manager)Craig-Hallum (lead manager)Rosenblatt Securities (lead manager)SoFi Securities (lead manager)Fenwick & West (issuer)Cravath, Swaine & Moore (lead manager)Whalen LLP (issuer) BitGo Holdings IPO

Activity

Deals by year
Wedbush Securities: deals by year2025: 0, 2026 YTD: 190510152020252026 YTD: 10 M&A2026 YTD: 9 Equity raisings192026 YTDM&AEquity raisings

By announcement date; raisings and IPOs by their own date.

Deals by sector
Wedbush Securities: deals by sectorBiotech15Hardware & Semiconducto…2Crypto & Web31Industrial Services1

Sector of the business bought or funded.

Deals by size
Wedbush Securities: deals by sizeUnder US$100m1US$100–500m6US$500m–1bn1US$1bn+2Undisclosed9

Disclosed value in US dollars.

Most often across the table

Firms advising the other side of the same deals.

Repeat clients

  • Avere Therapeutics2 deals
  • Mentari Therapeutics2 deals
  • Odyssey Therapeutics2 deals

Offices and contact

Contact

From the firm's own website.

Suggest a correction

A missing deal, a wrong role or an office to add. A link to a public source helps.